• Price to earnings forward of Belite Bio, Inc – NASDAQ:BLTE TradingView Sat, 27 Jun 2026 22:26:49 GMT
• enterprise value to revenue forward of belite bio, inc – nasdaq:blte TradingView Fri, 26 Jun 2026 00:56:30 GMT
• enterprise value to ebitda forward of belite bio, inc – boats:blte TradingView Thu, 25 Jun 2026 19:31:47 GMT
• enterprise value to revenue forward of belite bio, inc – boats:blte TradingView Thu, 25 Jun 2026 14:05:22 GMT
• Understanding the Setup: (BLTE) and Scalable Risk Stock Traders Daily Thu, 25 Jun 2026 04:02:01 GMT
• Belite Bio (BLTE) After Its FDA Filing, Does The Stock Still Look Undervalued simplywall.st Thu, 25 Jun 2026 00:51:10 GMT
• we think belite bio (nasdaq:blte) can easily afford to drive business growth 富途牛牛 Mon, 22 Jun 2026 12:31:58 GMT
• form 4 belite bio inc adr for: 22 june by investing.com Investing.com Nigeria Mon, 22 Jun 2026 10:30:05 GMT
• Bioptima Ltd. tied to Belite Bio (BLTE) CMO sells 10,000 ADSs in open market Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Belite Bio CMO Scholl sells over $1.45m in company shares Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Why Belite Bio (BLTE) Is Up 5.8% After Completing FDA NDA Submission For Tinlarebant simplywall.st Sun, 21 Jun 2026 07:00:00 GMT
• belite bio inc (blte) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• belite bio inc (blte) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 10:06:38 GMT
• belite bio inc (blte) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:33:48 GMT
• Dr. Hendrick Scholl sells 10,000 ADS as Form 144 filed (NASDAQ: BLTE) Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Belite Bio (BLTE) Slips 1.5% as Stock Approaches Critical Support at $138.81 - Adaptive Moving Average dars.gov.et Thu, 18 Jun 2026 07:00:00 GMT
• belite bio inc (blte) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:06:16 GMT
• belite bio inc (blte) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 00:53:48 GMT
• Belite Bio Inc (BLTE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 20:18:06 GMT
• belite bio inc (blte) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 13:21:09 GMT
• belite bio inc (blte) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 13:20:44 GMT
• belite bio insider sold shares worth $1,405,729, according to a recent sec filing 富途牛牛 Wed, 17 Jun 2026 10:09:11 GMT
• Belite Bio (BLTE) CMO-affiliated entity sells 10,000 ADS, retains 32,946 Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Belite Bio CMO Scholl sells $1.4m shares from $137.61 to $145.02 Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• tinlarebant nda submission completed for stargardt disease type 1, targeting first approved therapy Ophthalmology Times Wed, 17 Jun 2026 07:00:00 GMT
• belite bio (blte) stock could be 35% undervalued after tinlarebant nda submission simplywall.st Wed, 17 Jun 2026 05:32:40 GMT
• analysts offer insights on healthcare companies: belite bio, inc. adr (blte), climb bio (clym) and intuitive surgical (isrg) The Globe and Mail Tue, 16 Jun 2026 11:36:00 GMT
• Belite Bio completes rolling NDA submission of oral tinlarebant for Stargardt Eyes On Eyecare Tue, 16 Jun 2026 07:00:00 GMT
• Belite Bio stock price target maintained at $200 by H.C. Wainwright on NDA completion Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• BLTE (NASDAQ: BLTE) files Rule 144 notice to sell 10,000 ADS under vested RSUs Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• belite bio inc (blte) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• blte reiterated by hc wainwright & co. -- price target maintained at $200 GuruFocus Mon, 15 Jun 2026 15:21:30 GMT
• h.c. wainwright maintains belite bio(blte.us) with buy rating, maintains target price $200 富途牛牛 Mon, 15 Jun 2026 11:31:00 GMT
• BofA Securities Maintains Belite Bio(BLTE.US) With Buy Rating, Announces Target Price $200 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• belite bio completes rolling submission of nda to u.s. fda for tinlarebant TipRanks Sun, 14 Jun 2026 20:35:19 GMT
• what belite bio (blte)'s completed tinlarebant nda filing means for shareholders simplywall.st Sun, 14 Jun 2026 08:51:05 GMT
• the technical signals behind (blte) that institutions follow Stock Traders Daily Sun, 14 Jun 2026 02:50:01 GMT
• belite bio completes nda submission for tinlarebant, targeting stargardt disease treatment Quiver Quantitative Sat, 13 Jun 2026 07:00:00 GMT
• fda to review belite bio oral therapy for retinal disease with no treatment Stock Titan Sat, 13 Jun 2026 01:32:50 GMT
• belite bio (blte) edges higher as volume supports near-term range - hidden order newsline.com Sat, 13 Jun 2026 00:35:32 GMT
• Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treat... GlobeNewswire Fri, 12 Jun 2026 07:00:00 GMT
• We're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn Yahoo Finance Fri, 12 Jun 2026 07:00:00 GMT
• FDA to review Belite Bio oral therapy for retinal disease with no treatment Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• Belite Bio (NASDAQ: BLTE) completes FDA NDA submission for tinlarebant in Stargardt disease Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• belite bio (blte) declines 2.6%: support and resistance zones in focus after pullback - strangle setup newsline.com Mon, 08 Jun 2026 23:42:03 GMT
• a look at belite bio (blte) valuation after recent share price weakness simplywall.st Mon, 08 Jun 2026 13:17:56 GMT
• blte stock price, quote & chart | belite bio inc - adr (nasdaq:blte) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• Precision Trading with Belite Bio Inc (BLTE) Risk Zones Stock Traders Daily Wed, 03 Jun 2026 07:00:00 GMT
• Belite Bio (BLTE) Holds Steady Near Support as Traders Eye Breakout Potential - Factor ETF Flow dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• blte stock price, quote & chart | belite bio inc - adr (nasdaq:blte) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• goldman sachs healthcare conference to host belite bio fireside chat june 8 Stock Titan Tue, 02 Jun 2026 12:00:00 GMT
• Belite Bio to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• belite bio to present at goldman sachs healthcare conference on june 8, 2026 Pluang Tue, 02 Jun 2026 07:00:00 GMT
• belite bio (blte) declines 2.6% as shares approach critical support zone - iv rank dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• h.c. wainwright maintains belite bio(blte.us) with buy rating, maintains target price $200 富途牛牛 Sat, 30 May 2026 23:30:04 GMT
• press release: belite bio reports unaudited first quarter 2026 financial results and provides a corporate update Moomoo Fri, 29 May 2026 08:19:57 GMT
• a look at belite bio (blte) valuation after wider first quarter net loss and mixed share price moves simplywall.st Fri, 29 May 2026 07:00:00 GMT
• maxim group maintains belite bio(blte.us) with buy rating, maintains target price $200 Moomoo Thu, 28 May 2026 07:00:00 GMT
• will widening losses and renewed buy ratings change belite bio's (blte) narrative? simplywall.st Thu, 28 May 2026 07:00:00 GMT
• Belite Bio, Inc (BLTE) Presents at 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) - Slideshow (... Seeking Alpha Wed, 27 May 2026 07:00:00 GMT
• belite bio (blte) hovers near resistance as price action remains muted - point of control newsline.com Wed, 27 May 2026 07:00:00 GMT
• blte stock price, quote & chart | belite bio inc - adr (nasdaq:blte) ChartMill Wed, 27 May 2026 07:00:00 GMT
• belite bio shares rise after first-quarter earnings outperform expectations (blte) MSN Tue, 26 May 2026 13:18:38 GMT
• mizuho securities maintains belite bio(blte.us) with buy rating, cuts target price to $215 富途牛牛 Tue, 26 May 2026 12:30:25 GMT
• mizuho lowers belite bio stock price target to $215 on valuation Investing.com Canada Tue, 26 May 2026 07:00:00 GMT
• mizuho adjusts price target on belite bio to $215 from $223, maintains outperform rating Moomoo Tue, 26 May 2026 07:00:00 GMT
• lin bioscience (belite bio) completes enrollment for lbs-008 phase ii/iii dragon ii trial for stargardt disease 全球醫療採購網 Tue, 26 May 2026 07:00:00 GMT
• belite bio shares rise after first-quarter earnings outperform expectations (blte) MSN Sun, 24 May 2026 06:11:25 GMT
• technical reactions to blte trends in macro strategies Stock Traders Daily Sat, 23 May 2026 07:00:00 GMT
• belite bio shares rise after first-quarter earnings outperform expectations (blte) MSN Sat, 23 May 2026 00:14:41 GMT
• analysts are bullish on top healthcare stocks: belite bio, inc. adr (blte), centene (cnc) The Globe and Mail Fri, 22 May 2026 14:32:00 GMT
• Belite Bio, Inc 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:BLTE) 2026-05-22 Seeking Alpha Fri, 22 May 2026 07:00:00 GMT
• benchmark reiterates belite bio stock rating on drug development progress Investing.com Fri, 22 May 2026 07:00:00 GMT
• blte stock price, quote & chart | belite bio inc - adr (nasdaq:blte) ChartMill Fri, 22 May 2026 07:00:00 GMT
• cantor fitzgerald maintains belite bio(blte.us) with buy rating, maintains target price $266 富途牛牛 Thu, 21 May 2026 18:36:05 GMT
• belite bio inc (blte) q1 2026 earnings call highlights: strategic advancements amid rising expenses by gurufocus Investing.com Canada Thu, 21 May 2026 07:05:17 GMT
• belite bio, inc (nasdaq:blte) q1 2026 earnings call transcript Insider Monkey Thu, 21 May 2026 07:00:00 GMT
• h.c. wainwright reiterates belite bio stock rating on nda progress Investing.com Thu, 21 May 2026 07:00:00 GMT
• earnings call transcript: belite bio beats q1 2026 eps estimates, stock dips Investing.com Australia Thu, 21 May 2026 07:00:00 GMT
• blte stock price, quote & chart | belite bio inc - adr (nasdaq:blte) ChartMill Thu, 21 May 2026 07:00:00 GMT
• earnings call summary | belite bio(blte.us) q1 2026 earnings conference Moomoo Thu, 21 May 2026 06:37:36 GMT
• belite bio reports q1 2026 earnings with increased r&d and sg&a expenses Intellectia AI Thu, 21 May 2026 05:04:37 GMT
• belite bio (blte) is down 6.6% after swiss orphan status, fda filing progress for tinlarebant simplywall.st Thu, 21 May 2026 01:54:57 GMT
• blte: nda submission for stargardt disease progresses as expenses rise and commercial launch nears TradingView Wed, 20 May 2026 21:29:17 GMT
• belite bio reports q1 results: starts rolling nda for tinlarebant grafa.com Wed, 20 May 2026 17:18:00 GMT
• belite bio q1 net loss expands; plans to complete rolling nda submission for tinlarebant in q2 2026 RTTNews Wed, 20 May 2026 11:08:00 GMT
• belite bio kicks off tinlarebant nda and ramps up commercial build-out on strong cash base TipRanks Wed, 20 May 2026 10:50:10 GMT
• belite bio, inc reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 20 May 2026 10:02:00 GMT
• Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update GlobeNewswire Wed, 20 May 2026 07:00:00 GMT
• Belite Bio shares rise after first-quarter earnings outperform expectations (BLTE) Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• Tinlarebant earns Swiss orphan drug status for Stargardt disease Ophthalmology Times Wed, 20 May 2026 07:00:00 GMT
• earnings call transcript: belite bio beats q1 2026 eps estimates, stock dips Investing.com Wed, 20 May 2026 07:00:00 GMT
• belite bio begins fda filing for potential first stargardt drug, holds $798.6m Stock Titan Wed, 20 May 2026 07:00:00 GMT
• blte: net loss widened on higher r&d and sg&a; nda submission for tinlarebant in stgd1 progressing TradingView Wed, 20 May 2026 07:00:00 GMT
• belite bio (nasdaq: blte) starts tinlarebant nda as q1 2026 loss deepens Stock Titan Wed, 20 May 2026 07:00:00 GMT
• belite bio stock gains 2% on first-quarter earnings beat by investing.com Investing.com Nigeria Wed, 20 May 2026 07:00:00 GMT
• earnings flash (blte) belite bio, inc posts q1 adjusted loss $0.34 per share, vs. factset est of $-0.69 marketscreener.com Wed, 20 May 2026 07:00:00 GMT
• press release: belite bio reports unaudited first quarter 2026 financial results and provides a corporate update Moomoo Wed, 20 May 2026 07:00:00 GMT
• belite bio (blte) is down 6.6% after swiss orphan status, fda filing progress for tinlarebant Sahm Wed, 20 May 2026 07:00:00 GMT
• belite bio inc reports results for the quarter ended march 31 - earnings summary TradingView Wed, 20 May 2026 07:00:00 GMT
• blte: rolling nda for tinlarebant in stgd1 underway; q1 net loss widened amid robust cash reserves TradingView Wed, 20 May 2026 07:00:00 GMT
• belite bio initiates nda submission for tinlarebant in stargardt disease type 1, reports q1 2026 financial results Quiver Quantitative Wed, 20 May 2026 07:00:00 GMT
• belite bio to host webcast on may 20, 2026, to discuss first quarter 2026 financial results marketscreener.com Wed, 20 May 2026 07:00:00 GMT
• belite bio receives swiss orphan drug status for tinlarebant by investing.com Investing.com Australia Tue, 19 May 2026 07:00:00 GMT
• Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland GlobeNewswire Mon, 18 May 2026 07:00:00 GMT
• Swiss backs first potential Stargardt therapy, from Belite Bio Stock Titan Mon, 18 May 2026 07:00:00 GMT
• belite bio receives swiss orphan drug status for tinlarebant Investing.com Mon, 18 May 2026 07:00:00 GMT
• belite bio inc expected to post a loss of 64 cents a share - earnings preview TradingView Mon, 18 May 2026 07:00:00 GMT
• belite bio, inc - depositary receipt (blte) price target increased by 21.98% to 116.02 MSN Sun, 17 May 2026 00:12:12 GMT
• Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026) Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• teen eye disease drug tinlarebant slowed lesion growth 35.7% in trial Stock Titan Fri, 15 May 2026 07:00:00 GMT
• belite bio (blte.us) is scheduled to release its earnings report on may 20. 富途牛牛 Fri, 15 May 2026 02:33:11 GMT
• belite bio (blte) ceo & chairman reports 1.25m shares, including vested awards Stock Titan Thu, 14 May 2026 07:00:00 GMT
• transcript : belite bio, inc presents at bank of america global healthcare conference 2026, may-13-2026 03 marketscreener.com Thu, 14 May 2026 02:35:16 GMT
• blte: oral stargardt therapy shows 36% efficacy, poised for rapid u.s. launch and strong uptake TradingView Wed, 13 May 2026 23:39:57 GMT
• Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• drug developer belite bio to review q1 2026 finances in may 20 webcast Stock Titan Wed, 13 May 2026 07:00:00 GMT
• trading the move, not the narrative: (blte) edition Stock Traders Daily Mon, 11 May 2026 23:04:01 GMT
• hc wainwright & co. maintains belite bio, inc - depositary receipt (blte) buy recommendation MSN Mon, 11 May 2026 16:06:15 GMT
Belite Bio, Inc(NASDAQ:BLTE) 
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.
Website: https://belitebio.com/
Founded: 2016
IPO Price: $6 (Apr 29, 2022)
CEO / Founder: Dr. Tom Lin
Sector: Technology
Industry: General
Share this website to your friends